Cantor Fitzgerald Has Lowered Expectations for HCA Healthcare (NYSE:HCA) Stock Price

HCA Healthcare (NYSE:HCA) had its price objective cut by investment analysts at Cantor Fitzgerald from $588.00 to $525.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Cantor Fitzgerald’s price target indicates a potential upside of 25.90% from the company’s previous close.

Several other research firms have also recently weighed in on HCA. TD Cowen cut their target price on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Wall Street Zen downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Jefferies Financial Group reiterated a “buy” rating and issued a $525.00 target price on shares of HCA Healthcare in a research report on Friday, April 24th. Leerink Partners dropped their target price on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Finally, Barclays lowered their price objective on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Fifteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $500.14.

HCA Healthcare Stock Up 1.6%

HCA opened at $417.00 on Tuesday. HCA Healthcare has a twelve month low of $330.00 and a twelve month high of $556.52. The stock has a market capitalization of $92.51 billion, a price-to-earnings ratio of 14.34, a P/E/G ratio of 1.30 and a beta of 1.12. The company has a 50-day simple moving average of $400.65 and a 200 day simple moving average of $462.33.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The firm had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business’s revenue was up 4.3% on a year-over-year basis. During the same period last year, the company posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts anticipate that HCA Healthcare will post 30.07 EPS for the current fiscal year.

Institutional Trading of HCA Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in HCA. Palisade Asset Management LLC purchased a new position in HCA Healthcare during the 3rd quarter worth approximately $26,000. Holos Integrated Wealth LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth about $29,000. Ares Financial Consulting LLC acquired a new position in HCA Healthcare in the 4th quarter valued at about $31,000. Cedar Mountain Advisors LLC acquired a new stake in HCA Healthcare during the 1st quarter worth approximately $33,000. Finally, JPL Wealth Management LLC acquired a new position in shares of HCA Healthcare in the third quarter valued at approximately $33,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.